SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-121363
Filing Date
2017-04-12
Accepted
2017-04-12 16:08:32
Documents
7
Effectiveness Date
2017-04-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A d334588ddefa14a.htm DEFA14A 30352
2 GRAPHIC g334588logo.jpg GRAPHIC 6371
3 GRAPHIC g334588tx2.jpg GRAPHIC 2140
4 GRAPHIC g334588tx3.jpg GRAPHIC 3056
5 GRAPHIC g334588tx4.jpg GRAPHIC 9045
6 GRAPHIC g334588txpg01.jpg GRAPHIC 8319
7 GRAPHIC g334588txpg02.jpg GRAPHIC 8057
  Complete submission text file 0001193125-17-121363.txt   83188
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 17758082
SIC: 2834 Pharmaceutical Preparations